Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Mar 2025 IJTLD Open Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy Autoren Kuksa L et al. Feb 2025 Nat Commun Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice Autoren Ssebyatika G et al. Feb 2025 Am J Transplant Gut microbiome alterations precede graft rejection in kidney transplantation patients Autoren Holle J et al. Feb 2025 J Infect Dis Elucidating Infectious Causes of Fever of Unknown Origin: A Laboratory-Based Observational Study of Patients with Suspected Ebola Virus Disease, Guinea, 2014 Autoren Postigo-Hidalgo I et al. Jan 2025 Epid Bull Vernachlässigte Tropenkrankheiten – Gemeinsam handeln für eine Welt ohne NTDs Autoren Fastenau A et al. Jan 2025 Liver Int Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta Autoren Lampertico P et al. Jan 2025 Nat Commun Reverse mutational scanning of SARS-CoV-2spike BA.2.86 identifies epitopescontributing to immune escape frompolyclonal sera Autoren Bdeir N et al. Jan 2025 Nat Commun The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis Autoren Römpp A et al. Jan 2025 JHEP Rep Adapted hepatitis C virus clone infects innate immunity deficient mouse hepatocytes with minimal human HCV entry factors Autoren Sheldon JA et al. Jan 2025 The Lancet Microbe Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial Autoren Heinrich N et al. Dec 2024 Science Autologous DNA mobilization and multiplication expedite natural products discovery from bacteria Autoren Xie F et al. Dec 2024 Science Advances Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies Autoren Kumar Nagarathinam et al. Dec 2024 JAMA Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel Autoren Gandhi RT et al. Nov 2024 ACS Infect Dis In Vivo Activity Profiling of Biosynthetic Darobactin D22 Against Critical Gram-Negative Pathogens Autoren Kany AM et al. Oct 2024 BMC Infect Dis Resistance of Anopheles gambiae s.s. against commonly used insecticides and implication of cytochrome P450 monooxygenase in resistance to pyrethroids in Lambaréné (Gabon) Autoren Boussougou-Sambe ST et al. Oct 2024 Infection Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999-2023) Autoren Krings A et al. Oct 2024 Nucleic Acids Res BGC Atlas: a web resource for exploring the global chemical diversity encoded in bacterial genomes Autoren Bağcı C et al. Oct 2024 Hepatology Hepatitis D virus - still the devil ! Autoren Wranke A Wedemeyer H Oct 2024 Crit Care Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials Autoren Honoré PM et al. Oct 2024 Mycoses EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis Autoren Sehgal IS et al. Oct 2024 J Gen Virol Organotypic brain slices as a model to study the neurotropism of the highly pathogenic Nipah and Ebola viruses Autoren Gellhorn Serra M et al. Oct 2024 Lancet Infect Dis The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01(E) vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial Autoren Macià D et al. Oct 2024 Viruses Expanding Insights: Harnessing Expansion Microscopy for Super-Resolution Analysis of HIV-1-Cell Interactions Autoren Petrich A et al. Oct 2024 Biomedicines From Gut to Blood: Redistribution of Zonulin in People Living with HIV Autoren Augustin M et al. Oct 2024 Int J Mol Sci Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study Autoren Kumar S et al. Pagination < Zurück Current page 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Next page ››
Mar 2025 IJTLD Open Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy Autoren Kuksa L et al.
Feb 2025 Nat Commun Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice Autoren Ssebyatika G et al.
Feb 2025 Am J Transplant Gut microbiome alterations precede graft rejection in kidney transplantation patients Autoren Holle J et al.
Feb 2025 J Infect Dis Elucidating Infectious Causes of Fever of Unknown Origin: A Laboratory-Based Observational Study of Patients with Suspected Ebola Virus Disease, Guinea, 2014 Autoren Postigo-Hidalgo I et al.
Jan 2025 Epid Bull Vernachlässigte Tropenkrankheiten – Gemeinsam handeln für eine Welt ohne NTDs Autoren Fastenau A et al.
Jan 2025 Liver Int Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta Autoren Lampertico P et al.
Jan 2025 Nat Commun Reverse mutational scanning of SARS-CoV-2spike BA.2.86 identifies epitopescontributing to immune escape frompolyclonal sera Autoren Bdeir N et al.
Jan 2025 Nat Commun The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis Autoren Römpp A et al.
Jan 2025 JHEP Rep Adapted hepatitis C virus clone infects innate immunity deficient mouse hepatocytes with minimal human HCV entry factors Autoren Sheldon JA et al.
Jan 2025 The Lancet Microbe Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial Autoren Heinrich N et al.
Dec 2024 Science Autologous DNA mobilization and multiplication expedite natural products discovery from bacteria Autoren Xie F et al.
Dec 2024 Science Advances Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies Autoren Kumar Nagarathinam et al.
Dec 2024 JAMA Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel Autoren Gandhi RT et al.
Nov 2024 ACS Infect Dis In Vivo Activity Profiling of Biosynthetic Darobactin D22 Against Critical Gram-Negative Pathogens Autoren Kany AM et al.
Oct 2024 BMC Infect Dis Resistance of Anopheles gambiae s.s. against commonly used insecticides and implication of cytochrome P450 monooxygenase in resistance to pyrethroids in Lambaréné (Gabon) Autoren Boussougou-Sambe ST et al.
Oct 2024 Infection Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999-2023) Autoren Krings A et al.
Oct 2024 Nucleic Acids Res BGC Atlas: a web resource for exploring the global chemical diversity encoded in bacterial genomes Autoren Bağcı C et al.
Oct 2024 Crit Care Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials Autoren Honoré PM et al.
Oct 2024 Mycoses EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis Autoren Sehgal IS et al.
Oct 2024 J Gen Virol Organotypic brain slices as a model to study the neurotropism of the highly pathogenic Nipah and Ebola viruses Autoren Gellhorn Serra M et al.
Oct 2024 Lancet Infect Dis The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01(E) vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial Autoren Macià D et al.
Oct 2024 Viruses Expanding Insights: Harnessing Expansion Microscopy for Super-Resolution Analysis of HIV-1-Cell Interactions Autoren Petrich A et al.
Oct 2024 Biomedicines From Gut to Blood: Redistribution of Zonulin in People Living with HIV Autoren Augustin M et al.
Oct 2024 Int J Mol Sci Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study Autoren Kumar S et al.
